Hidetoshi Nitta

2.8k total citations
133 papers, 2.2k citations indexed

About

Hidetoshi Nitta is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Hidetoshi Nitta has authored 133 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 60 papers in Surgery and 45 papers in Oncology. Recurrent topics in Hidetoshi Nitta's work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Liver Disease Diagnosis and Treatment (27 papers). Hidetoshi Nitta is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Liver Disease Diagnosis and Treatment (27 papers). Hidetoshi Nitta collaborates with scholars based in Japan, France and United States. Hidetoshi Nitta's co-authors include Toru Beppu, Hiromitsu Hayashi, Akira Chikamoto, Daisuke Hashimoto, Katsunori Imai, Hirohisa Okabe, Hideo Baba, Shigeki Nakagawa, Hideo Baba and Takaaki Higashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hidetoshi Nitta

125 papers receiving 2.2k citations

Peers

Hidetoshi Nitta
Comparison fields: 5 of 99
  • Hepatology 757
  • Oncology 706
  • Surgery 550
  • Molecular Biology 536
  • Epidemiology 509
Yasunobu Matsuda Japan
Mitsuteru Natsuizaka Japan
Kazuyoshi Ohkawa Japan
Jonathan Fawcett Australia
Takatoshi Ishiko Japan
Purva Gopal United States
Matthew M. Yeh United States
Tianqiang Song China
Naoki Oishi Japan
Masahiro Ohira Japan
Yasunobu Matsuda Japan View profile →
Citations per field, relative to Hidetoshi Nitta
Hidetoshi Nitta · 1×
Citations per year, relative to Hidetoshi Nitta
Hidetoshi Nitta · 1×

Countries citing papers authored by Hidetoshi Nitta

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Nitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Nitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Nitta more than expected).

Fields of papers citing papers by Hidetoshi Nitta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Nitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Nitta. The network helps show where Hidetoshi Nitta may publish in the future.

Co-authorship network of co-authors of Hidetoshi Nitta

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Nitta. A scholar is included among the top collaborators of Hidetoshi Nitta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Nitta. Hidetoshi Nitta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor Anticancer Research Hirohisa Okabe, Hidetoshi Nitta et al. 2
2 Prognostic value of preoperative geriatric nutritional risk index in intrahepatic cholangiocarcinoma after hepatectomy: a single‑center retrospective cohort study Langenbeck s Archives of Surgery Daisuke Ogawa, Tatsunori Miyata et al. 0
3 Perioperative disabilities in activities of daily living are associated with worse prognosis after hepatectomy for colorectal liver metastasis HPB Kosuke Mima, Hiromitsu Hayashi et al. 0
4 Conversion Surgery for Hepatocellular Carcinoma Following Molecular Therapy Anticancer Research Kensuke Yamamura, Toru Beppu et al. 7
5 How to treat remnant cholecystitis after subtotal cholecystectomy: two case reports SHILAP Revista de lepidopterología Hidetoshi Nitta, Kazuto Harada et al. 2
6 The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma Annals of Surgical Oncology Tatsunori Miyata, Hiromitsu Hayashi et al. 4
7 Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes Medical Oncology Hidetoshi Nitta, Takayuki Shimose et al. 20
8 Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma Surgery Today Hidetoshi Nitta, Shigeki Nakagawa et al. 11
9 Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma Pancreas Daisuke Hashimoto, Kota Arima et al. 32
10 An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Cancer Research Hiromitsu Hayashi, Takaaki Higashi et al. 121
11 The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms Journal of Gastrointestinal Surgery Kota Arima, Hirohisa Okabe et al. 36
12 Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness Oncology Reports Hidetoshi Nitta, Yoji Murakami et al. 54
13 Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88) Clinical Cancer Research Hidetoshi Nitta, Yoshihiro Wada et al. 84
14 Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis Annals of Surgical Oncology Shigeki Nakagawa, Hirohisa Okabe et al. 52
15 The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers International Journal of Clinical Oncology Yoshiaki Ikuta, Hiroshi Takamori et al. 14
16 CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma British Journal of Cancer Hirohisa Okabe, Takatsugu Ishimoto et al. 57
17 Production of C5a by ASP, a Serine Protease Released from Aeromonas sobria The Journal of Immunology Hidetoshi Nitta, Takahisa Imamura et al. 20
18 Induction of Vascular Leakage and Blood Pressure Lowering through Kinin Release by a Serine Proteinase from Aeromonas sobria The Journal of Immunology Takahisa Imamura, Hidetomo Kobayashi et al. 30
19 A Case of Superior Mesenteric Venous Thrombosis Successfully Treated in Two-Stage Operation The Japanese Journal of Gastroenterological Surgery Hidetoshi Nitta, Yoshihisa Shibata et al. 5
20 Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: A prospective study in node-negative breast cancer Surgery Yasuhiro Okumura, Shogo Nakano et al. 36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026